ZEUS System (Zio Watch) vs Cardiomo
AI Verdict
Choose ZEUS System (Zio Watch) if…
Choose ZEUS System (Zio Watch) if your primary focus is long-term, continuous cardiac monitoring specifically for the detection and characterization of Atrial Fibrillation (AFib) and other complex arrhythmias, requiring high physician agreement on actionable insights. This tool is ideal for clinical settings where detailed, AI-powered analysis of ECG and PPG data over an extended period (up to 14 days) is crucial for diagnosis and treatment planning.
View ZEUS System (Zio Watch) →Choose Cardiomo if…
Choose Cardiomo if you need a medical-grade wearable for continuous, remote heart health monitoring with a broader focus on detecting various cardiovascular diseases and providing real-time, life-saving alerts to both users and caregivers. This tool is particularly well-suited for proactive patient management, especially in scenarios where immediate notification of vital sign abnormalities and potential cardiovascular events, including fall detection, is a priority.
View Cardiomo →When choosing between the ZEUS System (Zio Watch) and Cardiomo, physicians should consider their primary monitoring objectives and desired level of detailed cardiac analysis. The ZEUS System, from iRhythm Technologies, is specifically engineered for long-term continuous cardiac monitoring, excelling in the detection and characterization of Atrial Fibrillation (AFib) and other arrhythmias over a period of up to 14 days. Its AI-powered algorithm provides actionable insights and boasts high physician agreement on its clinically actionable reports. This makes it particularly well-suited for cardiologists and family medicine practitioners focused on diagnosing and managing AFib burden.
In contrast, Cardiomo offers a broader approach to remote heart health monitoring with its medical-grade wearable patch, continuously tracking vital signs such as ECG, heart rate, respiration, and skin temperature. While it also utilizes AI for detecting cardiovascular diseases and arrhythmias, its key practical difference lies in its emphasis on real-time alerts and notifications for users and caregivers, alongside features like fall detection. Cardiomo’s focus on immediate alerts and a wider range of vital sign monitoring makes it a strong contender for physicians in geriatrics or internal medicine who prioritize comprehensive, ongoing surveillance and timely intervention for a broader spectrum of cardiovascular concerns, potentially for a more general patient population.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | ZEUS System (Zio Watch) | Cardiomo |
|---|---|---|
| Pricing | Contact vendor | Contact for pricing |
| Deployment | Cloud-based system with a wearable device | Cloud-based with wearable device and mobile app |
| FDA Status | 1 AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
CardiomoCardiomo appears to have a slight edge in usability due to its patch-based design, which may offer more comfort and discretion compared to a wrist-worn watch for continuous wear. Additionally, its waterproof nature allows for use during activities like swimming, enhancing patient convenience.
Clinical Value
ZEUS System (Zio Watch)The ZEUS System (Zio Watch) has strong clinical validation, with FDA 510(k) clearance specifically for detecting and characterizing AFib, and studies showing high physician agreement (99%) with its reports. While Cardiomo is medical-grade and ISO 13485 certified, its FDA approval status is not explicitly stated as cleared, and detailed clinical validation results are less prominent in the provided information.
Pricing & Value
TieBoth tools require contacting the vendor for current pricing, making a direct comparison difficult. Cardiomo previously offered a public price, but this is no longer current. Without transparent and comparable pricing, it's not possible to determine which offers better value.
Enterprise Readiness
ZEUS System (Zio Watch)ZEUS System (Zio Watch) is developed by iRhythm Technologies, a leading digital healthcare solutions company, and was produced in partnership with Verily, an Alphabet precision health company, suggesting a strong foundation for enterprise integration and scalability. Cardiomo has pilot projects and partnerships, but the scale and depth of enterprise readiness are not as clearly articulated as for Tool A.
Innovation
TieBoth tools demonstrate innovation in continuous cardiac monitoring using AI and wearable technology. ZEUS System leverages a large repository of ECG data for its AI algorithms and focuses on characterizing AFib burden. Cardiomo offers a comprehensive set of vital sign monitoring and real-time alerts, including fall detection, showcasing a broader scope of innovative features.
Support & Docs
ZEUS System (Zio Watch)iRhythm Technologies provides a dedicated patient support FAQ, clinical resource center with numerous scientific manuscripts, and readily available instructions for use, indicating a robust support and documentation framework. Information regarding Cardiomo's specific support and documentation resources is not as detailed in the provided data.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | ZEUS System (Zio Watch) | Cardiomo |
|---|---|---|
| Name | ZEUS System (Zio Watch) | Cardiomo |
| Company | iRhythm Technologies | Cardiomo, Inc. |
| Description | FDA-cleared, AI-powered wearable for long-term continuous cardiac monitoring, specifically designed to detect and characterize Atrial Fibrillation (AFib) and other cardiac arrhythmias, providing actionable insights for physicians. | A medical-grade wearable device and an AI-powered platform for continuous and remote heart health monitoring, designed to detect cardiovascular diseases and provide timely alerts to users and caregivers. |
| Key Features (Monitoring) | Continuous ECG and PPG data collection; Long-term continuous monitoring for up to 14 days; Detects and characterizes Atrial Fibrillation (AFib) burden | Continuous vital sign monitoring (ECG, heart rate, respiration, skin temperature); Long battery life (up to 7-10 days) |
| Key Features (Alerts/Reporting) | AI-powered algorithm for advanced arrhythmia detection and analysis; Clinically actionable reports with high physician agreement (99%); ZioSuiteu00ae portal and provider mobile app for report interpretation and patient management; MyZiou00ae patient app for digital symptom logging, educational content, and reminders | AI-powered disease detection (arrhythmias, cardiovascular events); Real-time alerts and notifications; Mobile application (Android and iOS); Fall detection |
Videos
Demos, reviews, and walkthroughs featuring ZEUS System (Zio Watch) and Cardiomo.
Frequently Asked Questions
More Comparisons
More matchups featuring ZEUS System (Zio Watch) or Cardiomo
Backers
Who funded each tool's parent company.